Scott Lucchese

Associate Professor

UAMS

Also affiliated: Grant Medical Center (2022); Grant Medical College and Sir Jamshedjee Jeejeebhoy Group of Hospitals (2022–2024); Singapore General Hospital (2022–2024); University of Arkansas Medical Center (2022); University of Missouri Hospital (2024); University of Missouri Health System (2019–2022); Scottish Government (2020); Emergency University (2022); University of Missouri (2006–2024)

Faculty Researcher

Neurology, College of Medicine

5 h-index 19 pubs 57 cited

Research Areas

Biomedical Subjects

Links

Research Group UAMS TRI Profile

OverviewAI-generated summary

Scott Lucchese's research focuses on neurological disorders and their treatments, with a particular emphasis on headache management and the application of novel therapeutic approaches. He has investigated the comparative efficacy of Onabotulinum toxin A and incobotulinum toxin A for chronic migraine, examining factors such as effectiveness, tolerability, duration of effect, and injection site pain. His work also extends to rare neurological presentations, including abulia following a tick bite, potentially linked to alpha-gal driven hypothalamic dysfunction, and unusual headache presentations associated with COVID-19. Lucchese has explored the use of advanced imaging techniques, such as T2-SPACE MRI, for diagnosing spontaneous intracranial hypotension. Additionally, his research interests include investigating adverse drug reactions, such as domperidone-induced dystonia, and complications of viral reactivation in immunocompromised patients, as seen in a case of varicella-zoster reactivation in a multiple sclerosis patient.

Metrics

h-index: 5
Publications: 19
Citations: 57

Selected Publications

A Retrospective Comparison of Onabotulinum Toxin A and Incobotulinum Toxin A in Terms of Efficacy, Tolerability, Duration of Effect, and Pain on Injection Administration Site for the Treatment of Chronic Migraine (2024)

Cureus 2 citations DOI OpenAlex
Onabotulinum toxin A vs. incobotulinum toxin A for the treatment of chronic migraine: a retrospective review (2023)

Research Square 3 citations DOI OpenAlex
Unusual Presentation of COVID-19 Headache and Its Possible Pathomechanism (2022)

Cureus 4 citations DOI OpenAlex
Artificial Intelligence-Aided Headache Classification Based on a Set of Questionnaires: A Short Review (2022)

Cureus 6 citations DOI OpenAlex
T2-Sampling Perfection With Application-Optimized Contrasts by Using Flip Angle Evolution (SPACE) Protocol MRI: A Safe, Minimally Invasive Screening Tool for Spinal CSF Leak Causing Spontaneous Intracranial Hypotension (2022)

Cureus DOI OpenAlex
Novel Case Presentation of Abulia After Lone Star Tick Bite As Evidenced by Raised Titers of Alpha-Gal Specific IgM Immunoglobulin and a Possibility of Alpha-Gal Driven Hypothalamic Dysfunction As the Pathomechanism (2022)

Cureus 6 citations DOI OpenAlex
A Rare Case of Domperidone-Induced Acute Dystonia in a Young Adult Due to Consumption of Combination Drug (Proton Pump Inhibitors With Domperidone) and Its Possible Pathomechanism (2022)

Cureus 1 citation DOI OpenAlex
Varicella-Zoster Reactivation in a Non-immunized Elderly Multiple Sclerosis Patient While on Delayed-Release Dimethyl Fumarate With Grade 2 Lymphopenia and Profoundly Low CD4+ and CD8+ Cell Counts: A Case Report (2022)

Cureus 2 citations DOI OpenAlex
Laugh Headache, Not a Joke! A Case Report (2022)

Cureus DOI OpenAlex